Fig. 2
From: Cardiovascular outcomes between COVID-19 and non-COVID-19 pneumonia: a nationwide cohort study
Risk of cardiovascular outcomes in participants hospitalized for COVID-19 or non-COVID-19 pneumonia. The hazard ratios and 95% CIs have been estimated in the inverse probability of treatment-weighted COVID-19 (n = 125,810) and non-COVID-19 pneumonia (n = 28,492) groups. The length of the bar represents the incidence rates per 1,000,000 person-days. CI confidence interval, COVID-19 coronavirus disease 2019, MACE major adverse cardiovascular event, TIA transient ischemic attack. * A composite of myocardial infarction and stroke